ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Kitov Pharma Ltd

Kitov Pharma Ltd (KTOVW)

0.01401
0.00
(0.00%)
Closed March 29 04:00PM
0.00
0.00
(0.00%)

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

KTOVW News

Official News Only

KTOVW Discussion

View Posts
Dollar Bill Dollar Bill 3 years ago
I am going to need the price of KTOV to go up to $25 plus to be in the money on this POS.
πŸ‘οΈ0
zj3001 zj3001 3 years ago
No problem ??
πŸ‘οΈ0
dream_maker dream_maker 3 years ago
Thanks!
πŸ‘οΈ0
zj3001 zj3001 3 years ago
11/25/2020
πŸ‘οΈ0
Squirrely_McShitty Squirrely_McShitty 3 years ago
I have been out of this for months. I can't recall off the top of my head. You will have to look at the 10q or go through past posts. Sorry I can't be of more help.
πŸ‘οΈ0
dream_maker dream_maker 3 years ago
how much time is left on these warrants? Thanks
πŸ‘οΈ0
TripTrap TripTrap 4 years ago
Company Information
https://kitovpharma.investorroom.com/

Kitov Pharma is an innovative biopharmaceutical drug development company. Leveraging deep regulatory and clinical-trial expertise, Kitov’s veteran team of healthcare and business professionals maintains a proven track record in streamlined end-to-end drug development and approval. Kitov’s flagship combination drug, Consensiβ„’, achieved the primary efficacy endpoints for its Phase III and Phase III/IV clinical trials, and was approved by the U.S. FDA for patients suffering from osteoarthritis pain and hypertension. NT-219, which is developed by Kitov's majority-owned subsidiary, TyrNovo Ltd., is a novel patented small molecule designed to overcome cancer drug resistance that is currently in pre-clinical development. By lowering development risk and cost through fast-track regulatory approval of novel late-stage therapeutics, Kitov plans to deliver rapid ROI and long-term potential to investors, while making a meaningful impact on people’s lives.
πŸ‘οΈ0
TripTrap TripTrap 4 years ago
Here is a little more info:
https://en.globes.co.il/en/article-kitov-pharma-raises-35m-from-institutional-investors-1001333551
πŸ‘οΈ0
Fai 2 Fai 2 4 years ago
Maybe Merk?

https://twitter.com/StanTradingMan/status/1275919180857032705?s=19
πŸ‘οΈ0
Fai 2 Fai 2 4 years ago
From dankshy on ktov board


"Look for a PR to come out stating collaboration with Merck. They just got Keytruda fda approved....they tweeted about neck/head cancer.
Then check out KTOV tweet...they put β€œ#keytruda”
I smell a partner!"
πŸ‘οΈ0
Supersue Supersue 4 years ago
People will be loading going long.Be patient imo.
πŸ‘οΈ0
Supersue Supersue 4 years ago
KTOV moving up now
πŸ‘οΈ0
Squirrely_McShitty Squirrely_McShitty 4 years ago
If $KTOVW doesn't move today, it never will.
πŸ‘οΈ0
Supersue Supersue 4 years ago
KTOVW I'm loaded and waiting for the run.
πŸ‘οΈ0
weedtrader420 weedtrader420 4 years ago
KTOVW $$$$$$ WOW :D $0.25 TARGET PRICE WOOHOOOOOOOOOOOOO
πŸ‘οΈ0
weedtrader420 weedtrader420 4 years ago
WOOHOOOOOOO KTOVW$$$$$$ WOW grand slammer here
πŸ‘οΈ0
dream_maker dream_maker 4 years ago
You waited this long, why not wait a little longer? I’m expecting to see the drugs start bring in money. These warrants I hope will return to higher levels since the dilution is behind them. I know a real shit management team.
πŸ‘οΈ0
stock1ace1 stock1ace1 6 years ago
Gap filled
πŸ‘οΈ0
stock1ace1 stock1ace1 6 years ago
.75 x .82 ~ fda news, nda accepted for reveiew

https://finance.yahoo.com/news/kitov-announces-filing-fda-drug-110000894.html
πŸ‘οΈ0
LearnToTrade LearnToTrade 7 years ago
Oh boy, one year ago I bought my first batch of warrants at 52c on 2/9/16 thinking this was the best BIO that I ever found. This is fuck up as of today. Sold all my warrants today (some before market closed lucky that I followed my 6th sense.) Life move on...good luck guys.
πŸ‘οΈ0
scottsmith scottsmith 7 years ago
If commons doubled into and after the nda i may sell some warrants but not more than my initial investment. This is assuming commons at 4. But probably not.
πŸ‘οΈ0
zj3001 zj3001 7 years ago
Are you planning on sell after the announcement, or hold for a BO or FDA approval?
πŸ‘οΈ0
scottsmith scottsmith 7 years ago
Well they didn't pr the 6 month stability until December 7 I believe. Those results were necessary for the nda.

From another one of your recent posts: I think kitov is looking for at least 200m in a BO (absolute minimum) and 75-100 million upfront in a licensing deal.
πŸ‘οΈ0
LearnToTrade LearnToTrade 7 years ago
Let see how it goes. :)

5) Why was the NDA date pushed back from Q4/16 to as long as Q1/17 (Mar 31). What are we
waiting on, exactly?

He was firm about the fact that this was NOT a delay. He said they had a few things that needed to be
completed beforehand, and that a December submission was going to be tough. He said it "may be
January, or perhaps February at the latest, but no further than that." They decided to say Q1/17 just to
be safe.
πŸ‘οΈ0
scottsmith scottsmith 7 years ago
I think 80 percent chance we see nda in january. I also have a lot of warrants. I don't know about retiring but I am expecting 6 figure profits after tax.
πŸ‘οΈ0
LearnToTrade LearnToTrade 7 years ago
Well, I am betting big on this one. Hopefully we all get rich in 2017 AND RETIRE… Happy new year to all!! How many of you expected NDA will file around end of Jan besides me?
πŸ‘οΈ0
royzim royzim 7 years ago
This Black-Scholes model indicates a fair value of $1.98 with the common at $3.46 (today's close). I calculated the annualized volatility at 73% using one year of historical prices from NASDAQ. I assumed a risk-free return of 3% but the fair value isn't all that sensitive to it.

Here's the link
πŸ‘οΈ0
stocktrademan stocktrademan 7 years ago
KTOVW bullish 1.35






normal chart




log chart



πŸ‘οΈ0
LearnToTrade LearnToTrade 7 years ago
TOP 10 FUND HOLDING of KTOV


#10. Wells Fargo & Company MN 2,000
#09. UBS Group AG 2,547
#08. FNY Managed Accounts LLC 5,000
#07. Advisor Group Inc. 7,500
#06. Creative Planning 7,875
#05. Jane Street Group LC 11,314
#04. First Allied Advisory S Inc. 15,000
#03. Menta Capital LLC 16,084
#02. KCG Holdings Inc. 33,176
#01. Sabby Management LLC 232,524
πŸ‘οΈ0
Piton Piton 7 years ago
Nice day, got back in @ 1.41 at the open.
πŸ‘οΈ0
LearnToTrade LearnToTrade 7 years ago
Premarket up huge, our warrants should hit at least 1.5 tomorrow. :)
πŸ‘οΈ0
Topgun21 Topgun21 7 years ago
KTOV & KTOVW.... Management looks like they have some good things up their sleeves!!

Perhaps a BO, licensing deal we shall see!!


KTOVW STRONG!!
πŸ‘οΈ0
LearnToTrade LearnToTrade 7 years ago
News: The Board determined to fill a vacancy on the Board, and to appoint, effective immediately, Ms. Leah Bruck to serve as a director of the Company.
πŸ‘οΈ0
Salvatore314 Salvatore314 7 years ago
What an upset
πŸ‘οΈ0
stock1ace1 stock1ace1 7 years ago
Ihub has $1.91
πŸ‘οΈ0
scottsmith scottsmith 7 years ago
What did warrants close at on Friday?
πŸ‘οΈ0
salgovernale69 salgovernale69 7 years ago
Volume/spread hasn't been there the last couple of days to be able to buy anything in bulk.
πŸ‘οΈ0
LearnToTrade LearnToTrade 7 years ago
I see the sellers are mostly gone on the warrants. Its hard to buy a big chunk of it unless you want to buy it 10c higher. I expected it will slowly moving up as we are getting closer and closer to NDA filing around year end to Jan'17.
πŸ‘οΈ0
stock1ace1 stock1ace1 7 years ago
Worth a read ~> Ceo Answers Questions ~~> http://www.sendspace.com/pro/dl/bwsn71
πŸ‘οΈ0
stock1ace1 stock1ace1 7 years ago
KTOVW ~ @$1.98
πŸ‘οΈ0
stock1ace1 stock1ace1 7 years ago
Gm KTOV & KTOVW shareholders :)
πŸ‘οΈ0
tjguy tjguy 7 years ago
Evening here, but good morning to you!

I have read up on it and I find it hard to understand.

The Black Scholes call option formula is calculated by multiplying the stock price by the cumulative standard normal probability distribution function. Thereafter, the net present value (NPV) of the strike price multiplied by the cumulative standard normal distribution is subtracted from the resulting value of the previous calculation. In mathematical notation, C = S*N(d1) - Ke^(-r*T)*N(d2). Conversely, the value of a put option could be calculated using the formula: P = Ke^(-r*T)*N(-d2) - S*N(-d1). In both formulas, S is the stock price, K is the strike price, r is the risk-free interest rate and T is the time to maturity. The formula for d1 is: (ln(S/K) + (r + (annualized volatility)^2 / 2)*T) / (annualized volatility * (T^(0.5))). The formula for d2 is: d1 - (annualized volatility)*(T^(0.5)).

The page where it shows how to figure the black scholes value gives you an answer. I think the current figure you get is 2.86 or something like that. My guess is that is current value of the warrant which means that the KTOV warrant is very undervalued right now according to that formula/model.

Is that the correct way to read the 2.86 figure?

Thanks.
πŸ‘οΈ0
ash111 ash111 7 years ago
Gm.tjguy. B&S calculation base on a few parameters .main parameter is time. Time worth money. Warrants expiration date is about 4 years.that's a long time. Just Google it, you will find a good explanation.
πŸ‘οΈ0
ash111 ash111 7 years ago
Gm.tjguy. B&S calculation base on a few parameters .main parameter is time. Time worth money. Warrants expiration date is about 4 years.that's a long time. Just Google it, you will find a good explanation.
πŸ‘οΈ0
tjguy tjguy 7 years ago
Ash,

If the Black-Scholes value is 2.85 or whatever, does that mean that is the price the warrants should be trading at to realize the full current value?

Just not sure what the black-scholes number/value means.

Thanks.
πŸ‘οΈ0
ash111 ash111 7 years ago
Since many asking about Warrants via social networks, here some information I posted before:
KTOV/KTOVW Warrants can offer significant gains to an investor. If commons are trading $20 those Warrants will be trading at least $16.22 (20-3.78 ), 8.5 times investment return (at least, depends on remaining days till expiration date,could get an additional Premium) vs 5 times+ investment return if you own commons.
you can trade them like commons thats the beauty.
There should be a greater premium on warrants. 4 year exercise price (November 2020). That's a long time. B&S has a value of between 1.77-2.86 base on volatility 50-100% and current commons price:

https://www.mystockoptions.com/black-scholes.cfm?ticker=&s=4&x=3.78&t=4.1&r=3%25&v=100%25&calculate=Calculate

Will be better to Treat Warrants like a regular stock instead of exercising for several reasons: 

1. Fees and lock-up period if you exercise. 

2. Warrants not β€œin the money”. if warrants will not get a premium this might continue in the future as well

3. The warrants exercisable at 3.78, Expired 4 years out on 11/19/2020 and i find no reason to exercise them the upcoming year (even if "on the Money") due KIT-302 gonna hit the market in 2017 as represented by the company. there is also a Potential takeover target by Pfizer or another big Pharma before. all imo.

if you ask me, there is no chance of fully diluted the coming years, even not 50% imo, but even w/fully diluted(warrants) cap is still a joke relating a few hundred millions(sales) annually per experts. Fully diluted it's still only about a double current market cap and change company with 20m+ in cash.  Market Cap, Cash, sales prediction and Highlights can be found on KTOV board (sticky KTOV September 13th DD ).There is never 100% guarantee w/any stock but risk/reward ratio here, one of the most impressive I have seen.



πŸ‘οΈ0
salgovernale69 salgovernale69 7 years ago
Well nothing in life is a sure thing, but this is about as close as I've found to death and taxes lol!

I've long thought that they'd simply sell the company as well, but I got the impression that licensing might be their play at least initially. That's the avenue for the bigger return longer term, but the impatient retail in us all would love a buyout tomorrow.
πŸ‘οΈ0
LearnToTrade LearnToTrade 7 years ago
I just read the note. To me it sounds like a sure thing. This is crazy not to buy in. I hope buy out offers coming after NDA.
πŸ‘οΈ0
salgovernale69 salgovernale69 7 years ago
He did, I thought we put that in the notes, but he said latest would be January or worst case early February, but certainly could come earlier. He said there is no "delay" they've said for years that early 2017 was the target. They just want to make sure they have all their ducks in a row and the application is complete. I got the sense that he's under promising with the intent to over deliver.
πŸ‘οΈ0
stock1ace1 stock1ace1 7 years ago
Did he mention any timeframe on the NDA release ?
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock